Heerlen, NL, 08 May 2022 18:00 CEST
Royal DSM, a global purpose-led science-based company, today held its Annual General Meeting of Shareholders.
All the resolutions on the agenda were approved by the shareholders:
- The Remuneration Report received a positive advisory vote
- Adoption of the Financial Statements for 2021
- Adoption of the dividend on ordinary shares for 2021 (see also separate press release)
- Release from liability of the current and former members of the Managing Board in respect of their managerial activities
- Release from liability of the current and former members of the Supervisory Board in respect of their supervisory role
- Reappointment of Geraldine Matchett as a member of the Managing Board
- Reappointment of Eileen Kennedy as member of the Supervisory Board
- Reappointment of the external auditor (KPMG Accountants N.V.)
- Authorization of the Managing Board to issue up to 10% ordinary shares and to exclude pre-emptive rights
- Authorization of the Managing Board to issue an additional 10% ordinary shares in connection with a rights issue
- Authorization of the Managing Board to have the company repurchase shares
- Reduction of the issued capital by cancelling shares